Anti-DZIP3 antibody - 1mg/mL

Ref. 3D-CRB2005751

Informations sur le produit

• Nom: Anti-DZIP3 antibody - 1mg/mL

Description

E3 Ubiquitin ligase proteins mediate ubiquitination and subsequent proteasomal degradation of target proteins. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme as a thioester and then directly transfer the ubiquitin to targeted substrates. DZIP3 is located in the cytoplasm and can bind RNA specifically. DZIP3 enables several functions, including phosphatase binding activity; polyubiquitin modification-dependent protein binding activity; and ubiquitin-protein transferase activity. In addition, DZIP3 is involved in protein polyubiquitination._x000D_
_x000D_
The condition of azoospermia is associated with the deletion of DZIP3. High expression of DZIP3 is a biomarker for a poor outcome of several cancers, including gastric and breast cancer. DZIP3 is a crucial driver of cancer cell growth, migration, and invasion due to interacting with cyclin D1 during G1. In breast cancer, DZIP3 is a coactivator of oestrogen receptor α target gene expression and enhances their expression in breast cancer cells.

• Marque: Biosynth